Placebo control groups in randomized treatment trials: A statistician's perspective

Biological Psychiatry

Volumn 47, Issue 8, 2000, Pages 717-723

  Lavori, Philip W ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Control groups; Ethics; Placebo; Randomized trials

Indexed keywords

PLACEBO;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ETHICS; HUMAN; INFORMED CONSENT; METHODOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; STANDARD; STATISTICS;

EID: 0034655955     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00838-6     Document Type: Review

References (15)

1. Finkelstein M.O., Levin B., Robbins H. Clinical and prophylactic trials with assured new treatment for those at greater risk I, a design proposal . Am J Public Health. 86:1996;691-695.
2. Finkelstein M.O., Levin B., Robbins H. Clinical and prophylactic trials with assured new treatment for those at greater risk II, examples . Am J Public Health. 86:1996;696-705.
3. Gelenberg A.J., Kane J.M., Keller M.B., Lavori P.W., Rosenbaum J.F., Cole K., Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 321:1989;1489-1493.
4. Lavori P.W. Clinical trials in psychiatry Should protocol deviation censor patient data? Neuropsychopharmacology. 6:1992;39-63.
5. Lavori P.W., Bloch D.A., Bridge P.T., Leiderman D.B., LoCastro J.S., Somoza E. Plans, designs, and analyses for clinical trials of anti-cocaine medications Where we are today. NIDA/VA/SU Working Group on Design and Analysis . J Clin Psychopharmacol. 19:1999;246-256.
6. Lavori P.W., Dawson R. A design for testing clinical strategies Biased-coin adaptive within-subject randomization . J R Stat Soc A. 163:2000;29-38.
7. Lavori P.W., Sugarman J., Hays M.T., Feussner J.R. Improving informed consent in clinical trials A duty to experiment . Control Clin Trials. 20:1999;187-193.
8. Leber P.D. Hazards of inference The active control investigation . Epilepsia. 30:(suppl 1):1989;S57-S63.
9. Maj M.P., Magliano L., Bartoli L. Long term outcome of lithium prophylaxis in bipolar disorder. Am J Psychiatry. 155:1998;30-35.
10. Prien R.F., Kupfer D.J., Mansky P.A., Small J.G., Tuason V.B., Voss C.B., Johnson W.E. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine and a lithium carbonate-imipramine combination. Arch Gen Psychiatry. 41:1984;1096-1104.
11. Rosenheck R., Cramer J., Xu W., Thomas J., Henderson W., Frisman L., et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med. 337:1997;809-815.
12. Rothman K.J., Michels K.B. The continued unethical use of placebo controls. N Engl J Med. 31:1994;394-398.
13. Temple R (1996): Problems in interpreting active control equivalence trials. In: Accountability in Research, Vol 4. Amsterdam: Overseas Publishers Association, 267-275.
14. Wei L.J., Durham S. The randomized play-the-winner rule in medical trials. J Am Stat Assoc. 73:1978;840-843.
15. Zelen M. Play the winner rule and the controlled clinical trial. J Am Stat Assoc. 64:1969;131-146.